Breadcrumb Trail Links
GlobeNewswire
Article content
PHOENIX, March 19, 2025 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three and twelve months ended December 31, 2024. All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) unless otherwise indicated.
Advertisement 2
Article content
Article content
Article content
“2024 was a transformative year for TILT, as we took deliberate steps to streamline our business and sharpen our focus on Jupiter,” said TILT’s Chief Executive Officer, Tim Conder. “With the divestiture of our Massachusetts retail assets now underway, and a path toward exiting our remaining plant-touching operations, we are positioning TILT to emerge as a more agile, focused organization. This shift will allow us to unlock Jupiter’s full potential, expand our presence into new markets, and improve access to capital and financing opportunities.
“At Jupiter, we are making critical organizational enhancements, including leadership changes and operational improvements, which are essential to driving our business forward. The addition of experienced executives like Ken Yuan and Khalid Al Naser is key to this transformation as we enhance and expand our product portfolio and develop new proprietary hardware solutions tailored to today’s evolving consumer and regulatory landscape.”
Conder added, “Our work is far from over, but we are making important progress, as we break down and rebuild. Through all the challenges we have faced, our resilience has been a key strength. As we look ahead to 2025, we must remain focused and disciplined to achieve our strategic goals.”
Advertisement 3
Article content
Q4 2024 Financial Summary
Revenue was $24.6 million in the three months ended December 31, 2024, compared to $37.5 million in the prior year period. The decrease in revenue was primarily driven by the Company’s Jupiter Hardware business.Gross profit was $5.3 million and gross margin was 22% in the three months ended December 31, 2024, compared to $3.6 million or 10% of revenue in the prior year period. The increase in gross profit and margin was primarily driven by the Company’s transition to a commission-based model for certain Jupiter customers.Net loss was $41.4 million in the three months ended December 31, 2024, compared to a net loss of $22.0 million in the prior year period. The increase in net loss for the fourth quarter was attributed to intangible asset impairments and fair value measurements.Adjusted EBITDA (non-GAAP) was $0.5 million in the three months ended December 31, 2024, compared to $(1.6) million in the prior year period driven by gross margin and cash operating expense improvements.Cash used in operating activities in the fourth quarter was $0.5 million compared to cash provided by operating activities of $4.0 million for the year-ago period.At December 31, 2024, the Company had $4.3 million of cash, cash equivalents and restricted cash compared to $3.3 million at December 31, 2023.
Article content
Advertisement 4
Article content
Q4 2024 & Recent Operational Highlights
Announced a definitive agreement to sell Massachusetts retail locations to In Good Health for $2 million, with regulatory approvals expected in Q2 2025.Announced Adam Draizin stepped down from the Company’s Board of Directors and the appointment of Marshall P. Horowitz to fill his Board seat.
FY 2024 Financial Summary
Revenue was $115.6 million in the twelve months ended December 31, 2024, compared to $166.0 million in the prior year.Gross Profit was $20.1 million in the twelve months ended December 31, 2024, or approximately 17% of revenue, compared to $24.4 million or 15% of revenue in the prior year.Net loss was $99.7 million in the twelve months ended December 31, 2024, compared to a net loss of $62.4 million in the prior year. The increase in net loss was primarily driven by an increase in operating expenses predominantly due to increased non-cash impairment loss.Adjusted EBITDA (non-GAAP) was a loss of $2.2 million in the twelve months ended December 31, 2024, compared to $2.1 million in the prior year.Cash used in operating activities was $0.2 million for the twelve months ended December 31, 2024, compared to cash provided by operating activities of $5.4 million in the prior year.Notes payable net of discount at December 31, 2024 was $72.1 million compared to $52.2 million at December 31, 2023.
Advertisement 5
Article content
Earnings Call and Webcast
TILT management will host a conference call today at 5:00 p.m. Eastern time to discuss its financial and operational results, business strategy and future outlook, followed by a question-and-answer period.
Date: Wednesday, March 19th, 2025
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (877) 423-9813
International dial-in number: (201) 689-8573
Webcast:
TILT Q4 & FY 2024 Earnings Call
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Elevate IR at (720) 330-2829.
The conference call will also be available for replay in the investor relations section of the Company’s website at www.tiltholdings.com.
About TILT
TILT Holdings manages a diverse portfolio of companies in the cannabis industry, encompassing technology, hardware, cultivation, and production. Its core business, Jupiter Research LLC, is a wholly owned subsidiary and a global distribution leader in the vaporization segment. Jupiter is dedicated to hardware design, research, development, and distribution to support cannabis brands and retailers across the United States, Canada, South America, and the European Union. Additionally, TILT is a multi-state operator, with cultivation and production facilities in three states under the Commonwealth Alternative Care and Standard Farms brands. For more information, visit www.tiltholdings.com.
Advertisement 6
Article content
Forward-Looking Information
Advertisement 7
Article content
Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking information. Such risk factors include, but are not limited to, TILT’s ability to find a permanent successor executive, the impact of the announcement of the leadership change on TILT’s stock, performance, operations, results of operations, employees, suppliers and customers, TILT’s ability to successfully work through the leadership transition, TILT’s ability to execute on its business optimization strategy, capital preservation and cash generation, and reductions in corporate overhead and headcount and re-alignment of its business and those risks described under the heading “Item 1A Risk Factors” in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and “Item 1A Risk Factors” in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent reports filed by TILT with the United States Securities and Exchange Commission at www.sec.gov and on SEDAR+ at www.sedarplus.ca.
Advertisement 8
Article content
Non-GAAP Financial and Performance Measures
In addition to providing financial measurements based on GAAP, the Company provides additional financial metrics that are not prepared in accordance with GAAP. Management uses non-GAAP financial measures, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. These non-GAAP financial measures are Adjusted Gross Margin, Adjusted Net Income (Loss), EBITDA and Adjusted EBITDA. Management believes that these non-GAAP financial measures reflect the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-GAAP financial measures enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. These non-GAAP financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results.
Advertisement 9
Article content
As there are no standardized methods of calculating these non-GAAP measures, the Company’s methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others.
Accordingly, these non-GAAP measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP.
EBITDA and Adjusted EBITDA.
EBITDA and Adjusted EBITDA are financial measures that are not defined under GAAP. The Company uses these non-GAAP financial measures, and believes they enhance an investor’s understanding of the Company’s financial and operating performance from period to period, because they exclude certain material non-cash items and certain other adjustments management believes are not reflective of the Company’s ongoing operations and performance. EBITDA is calculated as EBITDA net income (loss), plus (minus) income taxes (recovery), plus (minus) finance expense (income), plus depreciation and amortization expense. Adjusted EBITDA is EBITDA excluding certain one-time, non-cash or non-operating expenses, as determined by management, including stock compensation expense, debt issuance costs and severance.
Advertisement 10
Article content
Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com
Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829
Advertisement 11
Article content
(Unaudited) Three Months Ended
Year Ended
December 31,
September 30,
December 31,
December 31,
December 31,
2024 2024 2023 2024 2023Net (loss) income before non-controlling interest$ (41,423) $ (12,649) $ (21,951) $ (99,670) $ (63,817) Add (Deduct) Impact of: Interest income (1) — — (4) — Interest expense 6,870 6,683 5,072 26,388 20,999 Income tax expense (benefit) 1,545 (1,405) 54 4,725 (3,339)Depreciation and amortization 5,342 5,356 5,726 22,064 24,139 Total Adjustments 13,756 10,634 10,852 53,173 41,799 EBITDA (Non-GAAP)$ (27,667) $ (2,015) $ (11,099) $ (46,497) $ (22,018) Add (Deduct) Impact of: Share-based compensation (178) 131 210 83 (1,665)Severance 404 48 (13) 473 1,067 (Gain) loss on sale of assets — — 2 — (8,882)Legal settlement 105 — — 105 258 Unrealized loss on investment in equity security — — — 1 6,401 Loss on loan receivable — — — — 5,602 Impairment loss and loss on disposal of assets 27,353 — 7,465 43,093 12,600 Foreign exchange (gain) loss — — (6) 4 12 Non-cash inventory adjustment 526 270 1,723 1,024 7,554 One time bad debt expense — — — — 384 One time adjustments — — 77 (465) 747 Total Adjustments 28,210 449 9,458 44,318 24,078 Adjusted EBITDA (Non-GAAP) 543 (1,566) (1,641) (2,179) 2,060 Net loss before non-controlling interest (41,423) (12,649) (21,951) (99,670) (63,817)Add (Deduct) Impact of: Impairment loss and loss on disposal of assets 27,353 — 7,465 43,093 12,600 Adjusted net loss before non-controlling interest (14,070) (12,649) (14,486) (56,577) (51,217)
Advertisement 12
Article content
December 31, 2024
December 31, 2023
Cash and cash equivalents$3,003 $2,034 Restricted cash 1,300 1,298 Trade receivables and others 11,904 17,919 Inventories 22,505 32,908 Total current assets 40,847 56,274 Property, plant & equipment, net 30,733 51,185 Total assets 151,324 231,188 Total current liabilities 87,455 76,072 Total long-term liabilities 101,071 92,723 Total shareholders’ equity (37,202) 62,393
Advertisement 13
Article content
2024 2024 2023 2024 2023Revenues, net$24,562 $26,967 $37,538 $115,614 $165,956 Cost of goods sold (19,280) (23,172) (33,958) (95,561) (141,580)Gross profit $ 5,282 3,795 3,580 20,053 24,376 Gross profit % 21.5% 14.1% 9.5% 17.3% 14.7% Add (Deduct) Impact of: One-time adjustment* — — 77 (465) 747 Non-cash inventory adjustment 526 270 1,723 1,024 7,554 Total Adjustments 526 270 1,800 559 8,301 Adjusted gross profit $ (Non-GAAP) 5,808 4,065 5,380 20,612 32,677 Adjusted gross profit % (Non-GAAP) 23.6% 15.1% 14.3% 17.8% 19.7% * One-time adjustment related to Taunton’s Host Fee Reversal

Article content
Share this article in your social network
